24 May 2013
Keywords: ec, clears, gsk, arixtra, prevention, vte, uk
Article | 14 February 2005
UK drug major GlaxoSmithKline says that the European Commission has approved the use of Arixtra (fondaparinux sodium) for the prevention ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
14 February 2005
© 2013 thepharmaletter.com